Digital Coming soon: New EU Artificial Intelligence Act Everyone is talking AI these days – and regulators are taking notice.
Sales & Marketing Sponsored Frontiers Health 2024: The foundational pillars Frontiers Health, a key player in health innovation, has announced the foundational pillars that will shape its legacy and future direction.
Oncology ASCO 2024: Emphasising the art and science behind enhanced c... The term “practice-changing” is often used when scientific advances promise to shift traditional treatment paradigms.
Sales & Marketing Power launch excellence with generative AI As debate about the usefulness and ethics of generative artificial intelligence (AI) continues, the pharmaceutical industry needs to consider the advantages it can offer, especially for inc
Digital Digital twins in healthcare and drug discovery: From idea to... The term "digital twins" has its origins in engineering and computer science, where it refers to a virtual replica of a physical object or system.
Sales & Marketing How data is critical to commercialising drugs for rare disea... Orphan drugs are designed to treat rare diseases, but “rare” is a relative term.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
